Development and Validation of a Microbiological Agar Assay for Determination of Orbifloxacin in Pharmaceutical Preparations
Open Access
- 29 August 2011
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 3 (3), 572-581
- https://doi.org/10.3390/pharmaceutics3030572
Abstract
Orbifloxacin is a fluoroquinolone with broad-spectrum antimicrobial activity, and belongs to the third generation of quinolones. Regarding the quality control of medicines, a validated microbiological assay for determination of orbifloxacin in pharmaceutical formulations has not as yet been reported. For this purpose, this paper reports the development and validation of a simple, sensitive, accurate and reproducible agar diffusion method to quantify orbifloxacin in tablet formulations. The assay is based on the inhibitory effect of orbifloxacin upon the strain of Staphylococcus aureus ATCC 25923 used as test microorganism. The results were treated statistically by analysis of variance and were found to be linear (r = 0.9992) in the selected range of 16.0–64.0 μg/mL, precise with relative standard deviation (RSD) of repeatability intraday = 2.88%, intermediate precision RSD = 3.33%, and accurate (100.31%). The results demonstrated the validity of the proposed bioassay, which allows reliable orbifloxacin quantitation in pharmaceutical samples and therefore can be used as a useful alternative methodology for the routine quality control of this medicine.This publication has 34 references indexed in Scilit:
- Approaches for application of sub and supercritical fluid extraction for quantification of orbifloxacin from plasma and milk: Application to disposition kineticsAnalytica Chimica Acta, 2009
- The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administrationJournal of Veterinary Pharmacology and Therapeutics, 2006
- Microbiological assay for gatifloxacin in pharmaceutical formulationsJournal of Pharmaceutical and Biomedical Analysis, 2006
- In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infectionsResearch in Veterinary Science, 2004
- Multiresidue determination of fluoroquinolone antibiotics in eggs using liquid chromatography–fluorescence–mass spectrometrynAnalytica Chimica Acta, 2003
- A Study of Metabolites Isolated from the Urine Samples of Cats and Dogs Administered Orbifloxacin.The Journal of Veterinary Medical Science, 1998
- Photodegradation Products of a New Antibacterial Fluoroquinolone Derivative, Orbifloxacin, in Aqueous Solution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1997
- Degradation Kinetics of the New Antibacterial Fluoroquinolone Derivative, Orbifloxacin, in Aqueous Solution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Photodegradation Kinetics of the New Antibacterial Fluoroquinolone Derivative, Orbifloxacin, in Aqueous Solution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Veterinary Use of New Quinolones in JapanDrugs, 1995